ENTITY

Jcr Pharmaceuticals (4552 JP)

25

Analysis

Health Care • Japan

JCR Pharmaceuticals Co., Ltd. develops, produces, and sells pharmaceutical products and raw materials. The Company also sells equipment for hospital and laboratory use. JCR Pharmaceuticals' products include drug for leukemic diseases and hormonal agents including genetically engineered human somatotrophic hormone (growth hormone) and gonadotropic hormone.

more

Refresh

Exchange Announcement • 19 Dec 2024 15:00

Jcr Pharmaceuticals Initiates Phase Iii Clinical Trial Of Jr-142 In Japan, A Long-Acting Growth Hormone Therapy

Exchange Announcement • 03 Dec 2024 15:00

Medipal Holdings Corporation And Jcr Pharmaceuticals Announce Initiation Of First Dosing In Phase I/Ii Clinical Trial Of Jr-446 For Mps Iiib In Japan

Exchange Announcement • 21 Nov 2024 15:00

Fy2024 R&Dmeeting Meterial

Exchange Announcement • 19 Nov 2024 12:00

Jcr Sponsors Family Health Activities At Organ Rooms Project

Exchange Announcement • 18 Nov 2024 13:30

[Delayed] Financial Summary Consolidated Financial Results For The Six Months Ended September 30, 2024 (Fy2024) (Japanese Standard)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x